Predictive Factors for Developing Venous Thrombosis during Cisplatin-Based Chemotherapy in Testicular Cancer

Publisher： Karger

E-ISSN： 1423-0399|99|1|104-109

ISSN： 0042-1138

Source： Urologia Internationalis, Vol.99, Iss.1, 2017-05, pp. : 104-109

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cisplatin-Based Chemotherapy for Testicular Germ Cell Tumors: Complication Rates of Peripheral versus Central Venous Administration

By  

Urologia Internationalis, Vol. 96, Iss. 2, 2016-0 ,pp. : 177-182

Karger

Access to resources Recommend Favorite

Outcome post‐neoadjuvant chemotherapy in elderly

By  

EUROPEAN JOURNAL OF CANCER CARE (ELECTRONIC), Vol. 24, Iss. 2, 2015-03 ,pp. : 155-162

John Wiley & Sons Inc

Access to resources Recommend Favorite

Nomogram for predicting survival in patients with unresectable and/or metastatic urothelial cancer who are treated with cisplatin‐based chemotherapy

By  

CANCER, Vol. 119, Iss. 16, 2013-08 ,pp. : 3012-3019

John Wiley & Sons Inc

Access to resources Recommend Favorite

Fatal Basilar Artery Thrombosis after Chemotherapy for Testicular Cancer

By  

Urologia Internationalis, Vol. 65, Iss. 1, 2000-08 ,pp. : 43-45

Karger

Access to resources Recommend Favorite

Biweekly Carboplatin/Gemcitabine in Patients with Advanced Urothelial Cancer Who Are Unfit for Cisplatin-Based Chemotherapy: Report of Efficacy, Quality of Life and Geriatric Assessment

By  

Oncology, Vol. 73, Iss. 5-6, 2008-05 ,pp. : 290-297

Karger

Access to resources Recommend Favorite